Skip to content
Careers
Contact us
Our Company
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Investors
Indications
Overview
Prader-Willi Syndrome
Non-alcoholic steatohepatitis
Type 1 Diabetes
Diabetic Nephropathy
Our Approach
Peripheral CB1 Blockade
The Endocannabinoid System
CB1 Inverse Agonists
Mechanism of Action of Peripheral CB1 Blockade
Our Pipeline
News & Events
FR
EN
Menu
Home
Our Company
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Investors
Indications
Overview
Prader-Willi Syndrome
Non-alcoholic steatohepatitis
Type 1 Diabetes
Diabetic Nephropathy
Our Approach
Peripheral CB1 Blockade
The Endocannabinoid System
CB1 Inverse Agonists
Mechanism of Action of Peripheral CB1 Blockade
Our Pipeline
News & Events
Careers
Media
Contact us
News
& Events
News
& Events
Latest
releases
National Institutes of Health Notice on Prospective Grant of Exclusive License.
